Chronic obstructive pulmonary disease (COPD) is a treatable disease characterized by
progressive airflow limitation. Prevention of disease progression, improvement of symptoms …

Introduction Natural history of chronic obstructive pulmonary disease (COPD) is punctuated
by exacerbations; however, little is known about prognosis of the first-ever COPD …

Background: A recent study found that short acting β agonists used in the treatment of
asthma and chronic obstructive pulmonary disease (COPD) may increase the risk of acute …

PURPOSE: To measure prevalence, incidence, and mortality of cardiovascular outcomes
among persons with chronic obstructive pulmonary disease (COPD) and to assess the …

The long-term use of inhaled anticholinergic agents has recently been suggested to be
associated with an excess risk of adverse cardiovascular (CV) outcomes in patients with …

Bronchodilators form the foundation of symptomatic treatment of COPD. Several long-acting
bronchodilators are now available for use in COPD, but publications of large-scale studies of …

Background Many persons with a history of smoking tobacco have clinically significant
respiratory symptoms despite an absence of airflow obstruction as assessed by spirometry …

We used the Manitoba Health database to examine the relationship between use of inhaled
respiratory drugs in people with chronic obstructive respiratory diseases and cardiovascular …

We review the cardiac safety of the drugs available at present for the maintenance treatment
of chronic obstructive pulmonary disease (COPD) in stable disease, focusing on inhaled …

The degree of acute improvement in spirometric indices after bronchodilator inhalation
varies among chronic obstructive pulmonary disease (COPD) patients, and depends upon …